Saving Millions on Cancer Drugs With Mark Cuban Plan

  • 📰 Medscape
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 55%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Huge savings could be made on generic oncology drugs if the current Part D Medicare formulary prices were replaced with pricing from the Mark Cuban Cost Plus Drug Company costplusdrugs according to a new study.

, last year, billionaire entrepreneur Mark Cuban, owner of the NBA's Dallas Mavericks, launched a company that offers generic drugs at prices that are substantially lower than the current market listings. It is now selling more than 350 generic prescription drugs at the cost of ingredients and manufacturing plus a 15% margin, a $3 pharmacy dispensing fee, and a $5 shipping fee. The company's inventory continues to expand.

The total savings ranged from $228.1 million to $2154.5 million , assuming plan prices were equal to the 25th or 75th percentiles of Q3-2022 Part D plan unit prices. All 30-day prescription drug prices offered by MCCPDC generated cost savings except for three drugs that were offered at the 25th percentile of Part D formulary pricing: anastrozole, letrozole, and tamoxifen.

The authors emphasize that the"cash-pay" prices offered by MCCPDC for several of oncology drugs, such as imatinib and abiraterone, were lower than what a person would pay using the Medicare Part D plans, even under catastrophic coverage.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in HEALTH

Health Health Latest News, Health Health Headlines